CARDIOVALVE

cardiovalve-logo

Cardiovalve is a medical device company developing a transfemoral mitral valve replacement system. The flagship Cardiovalve system is the first one designed to replace the mitral valve using a transfemoral system. It is designed from the bottom up for transfemoral/transseptal delivery with femoral venous access. Cardivalve approach offers significant benefits, including a short profile for minimal protrusion to the left ventricle, minimizing interference in the cardiac blood flow and increased safety. It is currently evaluating the safety and performance of its system in clinical studies and it will seek EU and US approval.

#People #Website #More

CARDIOVALVE

Social Links:

Industry:
Health Care Medical Medical Device

Founded:
2017-01-01

Address:
Or Yehuda, Tel Aviv, Israel

Country:
Israel

Website Url:
http://www.cardiovalve.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
300 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving


Current Employees Featured

amir-gross_image

Amir Gross
Amir Gross Co-founder & CEO @ Cardiovalve
Co-founder & CEO
2017-02-01

yossi-gross_image

Yossi Gross
Yossi Gross Co-founder @ Cardiovalve
Co-founder

Founder


amir-gross_image

Amir Gross

yossi-gross_image

Yossi Gross

Official Site Inspections

http://www.cardiovalve.com Semrush global rank: 7.41 M Semrush visits lastest month: 506

  • Host name: plesk.mixermedia.co.il
  • IP address: 185.70.250.163
  • Location: Israel
  • Latitude: 31.5
  • Longitude: 34.75
  • Timezone: Asia/Jerusalem

Loading ...

More informations about "Cardiovalve"

Home - Cardiovalve

The flagship Cardiovalve system is designed for transfemoral delivery, avoiding the need for open heart surgery. The Cardiovalve system offers significant benefits, including a short profile for …See details»

Cardiovalve - Crunchbase Company Profile & Funding

Organization. Cardiovalve . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Cardiovalve is a medical device company developing a …See details»

Cardiovalve Company Profile 2024: Valuation, Investors …

Cardiovalve General Information Description. Developer of a cardiovascular replacement device designed for minimally invasive surgery. The company's device is designed to replace regurgitating mitral and tricuspid valves, using a …See details»

Venus Medtech Acquires Cardiovalve to Optimize its Innovative …

Dec 8, 2021 Cardiovalve Ltd. was headquartered in Israel in 2010. With 40 employees, Cardiovalve operates from 1,700 sq. ft. facilities with inhouse manufacturing and clean rooms, …See details»

Cardiovalve - Contacts, Employees, Board Members, Advisors

Cardiovalve is a medical device company developing a transfemoral mitral valve replacement system.See details»

Cardiovalve - Foreign Startup | Startup Nation Finder

Aug 25, 2020 Cardiovalve is developing cardiovascular replacement devices for minimally invasive surgery. Its flagship system is designed to replace the mitral valve using a transfemoral system.See details»

Transcatheter Mitral Valve Implantation: Current Status …

Aug 19, 2021 The Cardiovalve system (Valtech Cardio, Ltd) features a self-expanding pericardial bovine valve mounted on a nitinol frame, ... The American Heart Association is a qualified 501(c)(3) tax-exempt organization. *Red Dress …See details»

Venus Medtech announces Cardiovalve acquisition

Dec 8, 2021 “The acquisition of Cardiovalve will create synergy with the company’s existing product layout and will further consolidate the company’s leading position in the field of structural heart disease in China and globally,” …See details»

Cardiovalve Transcatheter System gets US FDA …

Feb 21, 2020 The Cardiovalve transcatheter system is intended to replace regurgitating Mitral and Tricuspid valves, using a transfemoral – transseptal approach. ‬Credit: Cardiovalve. The US Food and Drug Administration (FDA) …See details»

Cardiovalve gets FDA breakthrough status for tricuspid valve ...

Feb 21, 2020 Cardiovalve spun out of Valtech Cardio at the time of the latter company’s acquisition by Edwards in 2017. With Edwards having two investigational mitral valve …See details»

Percutaneous Transcatheter Mitral Valve Replacement:

Jun 1, 2014 The Cardiovalve (Valtech Cardio Ltd, Or Yehuda, Israel) is a TMV prosthesis, designed to achieve fixation without radial force on the mitral annulus, yet obtaining full sealing and freedom from LVOT obstruction. ... The …See details»

Transcatheter Mitral Valve Replacement: An Update on Current …

The Cardiovalve (Or Yehuda, Israel) is a self-expanding bovine pericardial trileaflet valve within 2 frames, atrial and ventricular (Central Illustration E). It is available in 3 sizes (medium, large, …See details»

Transcatheter Mitral Valve Replacement in the Transcatheter Aortic ...

Nov 7, 2019 The AHEAD (European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System; NCT03339115) will evaluate the safety and the device performance in reducing …See details»

FDA grants breakthrough device status for Cardiovalve …

Feb 21, 2020 Primarily part of Valtech Cardio, which was acquired by Edwards Lifesciences in 2017, Cardiovalve is led by Valtech’s co-founder and CEO Amir Gross. Cardiovalve CEO Amir …See details»

3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients …

Organization, approvals, and role of the funding source. The protocol was designed by the principal investigators and sponsor in concert with the U.S. Food and Drug Administration. The …See details»

Cardiovalve scores FDA wins for its transcatheter tricuspid valve ...

Feb 20, 2020 Cardiovalve touted that it is the first privately held company to have the FDA early feasability study approval for both TR and MR (tricuspid/mitral regurgitation) indications.See details»

Cardiovalve receives Breakthrough Device Designation

Feb 21, 2020 Cardiovalve System. Cardiovalve has received US Food and Drug Administration (FDA) approval for an early feasibility study (EFS) of its transcatheter tricuspid valve …See details»

Cardiovalve Announces AHEAD US Study for Transcatheter Mitral …

Sep 20, 2018 About Cardiovalve: The flagship Cardiovalve system is a novel mitral valve designed for transfemoral/ transseptal use and intended to replace the mitral valve using a …See details»

About Heart Valves - American Heart Association

May 23, 2024 New to managing your heart valve condition? The American Heart Association encourages you to learn about how your heart works and how each of the valves function. …See details»

Heart Valve Voice Canada

The heart has four valves that open and close to control blood flow to your body. If one or more of those valves don’t open or close properly, that means you have heart valve disease.See details»